Delivery Order SPE2DB25D3017-SPE2DB25FVKJP
Award Date 8/25/25
Potential Completion Date 9/16/25
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 mg capsules (30-count) on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania. INGREZZA is a neurological medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a movement disorder associated with...
- The Defense Logistics Agency awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 mg capsules (30-count units) under a firm fixed-price contract. This non-set-aside award was issued on August 18, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. INGREZZA is a branded antipsychotic medication used to treat tardive dyskinesia, a neurological movement...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, and represents a non-set-aside competitive award. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. INGREZZA is a pharmaceutical treatment used in military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with a ceiling value of $4,027.70. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance to be completed by August 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will execute this order from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,027.70 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for INGREZZA 80 mg capsules (30-count units) with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The contractor will perform under this order at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of INGREZZA 80 mg capsules (30-count units) under a firm fixed-price arrangement valued at $4,027.70. This non-competitive delivery order is scheduled for completion by September 2, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used primarily for the treatment of tardive dyskinesia, a neurological movement...